Inventor · disambiguated record
Kristen Nicole Burford
Also filed as: BURFORD KRISTEN · Burford Kristen Nicole
12 granted patents·7 pending applications·31 citations·filing 2017–2024
88Inventor score
Top patents by PatentIndex Score
19 records- 0196US10815229B1Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Oct 27, 2020·4 cites·29 claims
- 0295US11299490B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·3 cites·24 claims
- 0392US10246453B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·10 cites·68 claims
- 0491US10662184B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted May 26, 2020·4 cites·3 claims
- 0590US11174268B2Benzenesulfonamide compouds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Nov 16, 2021·2 cites·25 claims
- 0689US10745392B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted Aug 18, 2020·4 cites·47 claims
- 0783US11325902B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·1 cites·33 claims
- 0882US10981905B2Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted Apr 20, 2021·1 cites·54 claims
- 0976US10787446B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Sep 29, 2020·1 cites·26 claims
- 1075US10752623B2Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitorsXENON PHARMACEUTICALS INC·Filed 2019·Granted Aug 25, 2020·1 cites·38 claims
- 1174US2025214970A1Pyridinylacetamide derivatives as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1271US2025129044A1Pyridinyl derivatives as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1370US2025059189A1Pyridine derivatives and their use as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1465US12054486B2Pyridine derivatives and their use as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2022·Granted Aug 6, 2024·0 cites·35 claims
- 1565US2023150972A1Pyridinyl derivatives as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1664US11639351B2Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2021·Granted May 2, 2023·0 cites·18 claims
- 1764US2023203007A1Pyridinylacetamide derivatives as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1860US2021171516A1Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 1947US2018162868A1Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kristen Nicole Burford files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →